SLCJY yields 6.50% · PFE yields 6.13%● Live data
📍 SLCJY pulled ahead of the other in Year 1
Combined, SLCJY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SLCJY + PFE for your $10,000?
SLC Agrícola S.A. produces and sells agricultural products in Brazil and internationally. The company's products include soybean, corn, and cotton crops, as well as soybean seeds, brachiaria seeds, mung beans, popcorn, seed corn, wheat, stylis, and permanent livestock. It also focuses on acquiring and developing land for agriculture. In addition, the company is involved in the cattle raising business; production and marketing of seeds and seedlings; property rental; and agro-industrial activities of industrialization of sugar cane, alcohol, and related derivatives, as well as provides reception, cleaning, drying, and storing of cereals. Further, it offers services with agricultural machinery and implements to third parties; and trades in, imports, and exports its agricultural products. The company was founded in 1977 and is headquartered in Porto Alegre, Brazil. SLC Agrícola S.A. is a subsidiary of SLC Participações S.A.
Full SLCJY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.